跳至主要内容
临床试验/NCT00763997
NCT00763997已完成不适用

Study of the Effect of Dipyrone, Ibuprofen, Paracetamol and Parecoxib on the Platelet Aggregation

Ruhr University of Bochum1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2004年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80
试验地点
1
主要终点
Percentage of aggregation in platelet rich plasma fter 24 hours of treatment with analgetic doses

研究概览

简要总结

Dipyrone is suggested to inhibit the platelet aggregation comparable to th effect of traditional analgetic substances like Ibuprofen. To verify this hypothesis the investigators conducted the study in comparing patients undergoing traumatologic, visceral or plastic surgical procedures. The investigators randomized them to four groups receiving common analgetic doses of either dipyrone, acetaminophen (paracetamol) or valdecoxib/parecoxib. The investigators took blood samples before initiation of the study drug, 1h, 4hs and 24hs after first intake. The investigators compared the aggregation via aggregometry of platelet rich plasma.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Planned traumatologic, orthopedic, visceral or plastic surgical procedures

排除标准

  • Prior intake of drugs with effect on the platelet aggregation
  • Patients with diseases of the gastrointestinal systems
  • Patients with cardiac or circulatory diseases
  • Patients receiving corticoids
  • Patients with cold or asthma
  • ASA-classification > 3

研究组 & 干预措施

1

Experimental

Dipyrone

干预措施: dipyrone (Drug)

1

Experimental

Dipyrone

干预措施: Blood samples (Other)

2

Active Comparator

Ibuprofen

干预措施: Ibuprofen (Drug)

2

Active Comparator

Ibuprofen

干预措施: Blood samples (Other)

3

Active Comparator

Acetaminophen

干预措施: Acetaminophen (Drug)

3

Active Comparator

Acetaminophen

干预措施: Blood samples (Other)

4

Placebo Comparator

Parecoxib/Valdecoxib

干预措施: Parecoxib/Valdecoxib (Drug)

4

Placebo Comparator

Parecoxib/Valdecoxib

干预措施: Blood samples (Other)

结局指标

主要结局

Percentage of aggregation in platelet rich plasma fter 24 hours of treatment with analgetic doses

时间窗: 24 hours

次要结局

  • Percentage of aggregation of platelet rich plasma 1hour and 4 hours after initiation of study drug(4 hours)

研究者

发起方
Ruhr University of Bochum
申办方类型
Other

研究点 (1)

Loading locations...

相似试验